PGHH Declares Interim Dividend of ₹195/Share, Record Date Feb 5
Procter & Gamble Hygiene and Health Care Limited declared an interim dividend of ₹195 per equity share for FY25-26, including a special ₹25 dividend. The record date is February 5, 2026, with payment by February 27, 2026. Unaudited financial results for the quarter ended December 31, 2025, were also approved.
The dividend declaration directly impacts shareholders and signals financial health. While positive, it is a routine event for many established companies and doesn't represent a fundamental shift in business strategy or a major corporate action that would warrant a 'HIGH' impact.
The declaration of an interim dividend, especially including a special one-time dividend, is generally viewed positively by investors, indicating strong financial performance and a commitment to shareholder returns.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced its unaudited financial results for the quarter ended December 31, 2025, following a Board of Directors meeting held on January 30, 2026. The meeting commenced at 12:54 PM and concluded at 1:57 PM.
During the meeting, the Board also declared an interim dividend for the Financial Year 2025-26. The dividend amounts to ₹195 per equity share, which includes a one-time special dividend of ₹25 per equity share. This interim dividend is scheduled to be paid on or before February 27, 2026.
For the purpose of determining eligibility for this interim dividend, the company has fixed the record date as February 5, 2026. The financial results presented are in accordance with Indian Accounting Standard 34 'Interim Financial Reporting'. The company's operating segments have been aggregated into a single primary reportable segment for health and hygiene products.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.